{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:16:58Z","timestamp":1793917018856,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:00:00Z","timestamp":1582588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04215"],"award-info":[{"award-number":["JP17H04215"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K08371"],"award-info":[{"award-number":["JP19K08371"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17H04215"],"award-info":[{"award-number":["JP17H04215"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tuberculosis (TB) caused by <jats:italic>Mycobacterium tuberculosis<\/jats:italic> (Mtb) is a global health problem. At present, prior exposure to Mtb can be determined by blood-based interferon-gamma release assay (IGRA), but active TB is not always detectable by blood tests such as CRP and ESR. This study was undertaken to investigate whether leucine-rich alpha-2 glycoprotein (LRG), a new inflammatory biomarker, could be used to assess active disease of TB. Cynomolgus macaques pretreated with or without Bacille Calmette-Guerin (BCG) vaccination were inoculated with Mtb to induce active TB. Blood was collected over time from these animals and levels of LRG as well as CRP and ESR were quantified. In the macaques without BCG vaccination, Mtb inoculation caused extensive TB and significantly increased plasma CRP and LRG levels, but not ESR. In the macaques with BCG vaccination, whereas Mtb challenge caused pulmonary TB, only LRG levels were significantly elevated. By immunohistochemical analysis of the lung, LRG was visualized in epithelioid cells and giant cells of the granulation tissue. In humans, serum LRG levels in TB patients were significantly higher than those in healthy controls and declined one month after anti-tubercular therapy. These findings suggest that LRG is a promising biomarker when performed following IGRA for the detection of active TB.<\/jats:p>","DOI":"10.1038\/s41598-020-60450-3","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T11:03:07Z","timestamp":1582628587000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Minoru","family":"Fujimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoshige","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Serada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yasutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Naka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,25]]},"reference":[{"key":"60450_CR1","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri2960","volume":"11","author":"G Walzl","year":"2011","unstructured":"Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J. & Zumla, A. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11, 343\u2013354, https:\/\/doi.org\/10.1038\/nri2960 (2011).","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"60450_CR2","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1016\/S1473-3099(18)30111-7","volume":"18","author":"Gerhard Walzl","year":"2018","unstructured":"Walzl, G. et al. Tuberculosis: advances and challenges in development of new diagnostics and biomarkers. Lancet Infect Dis, https:\/\/doi.org\/10.1016\/S1473-3099(18)30111-7 (2018).","journal-title":"The Lancet Infectious Diseases"},{"key":"60450_CR3","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1473-3099(13)70034-3","volume":"13","author":"RS Wallis","year":"2013","unstructured":"Wallis, R. S. et al. Tuberculosis biomarkers discovery: developments, needs, and challenges. Lancet Infect. Dis. 13, 362\u2013372, https:\/\/doi.org\/10.1016\/S1473-3099(13)70034-3 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"60450_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1473-3099(10)70071-2","volume":"10","author":"DJ Horne","year":"2010","unstructured":"Horne, D. J. et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect. Dis. 10, 387\u2013394, https:\/\/doi.org\/10.1016\/S1473-3099(10)70071-2 (2010).","journal-title":"Lancet Infect. Dis."},{"key":"60450_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1146\/annurev-med-040717-051502","volume":"70","author":"KV Dicks","year":"2019","unstructured":"Dicks, K. V. & Stout, J. E. Molecular Diagnostics for Mycobacterium tuberculosis Infection. Annu. Rev. Med. 70, 77\u201390, https:\/\/doi.org\/10.1146\/annurev-med-040717-051502 (2019).","journal-title":"Annu. Rev. Med."},{"key":"60450_CR6","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1473-3099(09)70042-8","volume":"9","author":"RS Wallis","year":"2009","unstructured":"Wallis, R. S. et al. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis. 9, 162\u2013172, https:\/\/doi.org\/10.1016\/S1473-3099(09)70042-8 (2009).","journal-title":"Lancet Infect. Dis."},{"key":"60450_CR7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.5588\/ijtld.17.0078","volume":"21","author":"C Yoon","year":"2017","unstructured":"Yoon, C. et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis. Int. J. Tuberc. Lung Dis. 21, 1013\u20131019, https:\/\/doi.org\/10.5588\/ijtld.17.0078 (2017).","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"60450_CR8","first-page":"309","volume":"79","author":"K Ito","year":"2004","unstructured":"Ito, K., Yoshiyama, T., Wada, M. & Ogata, H. C-reactive protein in patients with bacteriological positive lung tuberculosis. Kekkaku 79, 309\u2013311 (2004).","journal-title":"Kekkaku"},{"key":"60450_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/ard.2009.118919","volume":"69","author":"S Serada","year":"2010","unstructured":"Serada, S. et al. iTRAQ-based proteomic identification of leucine-rich alpha-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases. Ann. Rheum. Dis. 69, 770\u2013774, https:\/\/doi.org\/10.1136\/ard.2009.118919 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"60450_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.bbrc.2009.03.104","volume":"382","author":"R Shirai","year":"2009","unstructured":"Shirai, R., Hirano, F., Ohkura, N., Ikeda, K. & Inoue, S. Up-regulation of the expression of leucine-rich alpha(2)-glycoprotein in hepatocytes by the mediators of acute-phase response. Biochem. Biophys. Res. Commun. 382, 776\u2013779, https:\/\/doi.org\/10.1016\/j.bbrc.2009.03.104 (2009).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"60450_CR11","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1002\/ibd.22936","volume":"18","author":"S Serada","year":"2012","unstructured":"Serada, S. et al. Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis. Inflamm. Bowel Dis. 18, 2169\u20132179, https:\/\/doi.org\/10.1002\/ibd.22936 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"60450_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/ecco-jcc\/jjw132","volume":"11","author":"S Shinzaki","year":"2017","unstructured":"Shinzaki, S. et al. Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis. J. Crohns Colitis 11, 84\u201391, https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw132 (2017).","journal-title":"J. Crohns Colitis"},{"key":"60450_CR13","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1002\/art.39164","volume":"67","author":"M Fujimoto","year":"2015","unstructured":"Fujimoto, M. et al. Leucine-rich alpha2 -glycoprotein as a potential biomarker for joint inflammation during anti-interleukin-6 biologic therapy in rheumatoid arthritis. Arthritis Rheumatol. 67, 2056\u20132060, https:\/\/doi.org\/10.1002\/art.39164 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"60450_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijid.2017.01.030","volume":"56","author":"PJ Cardona","year":"2017","unstructured":"Cardona, P. J. & Williams, A. Experimental animal modelling for TB vaccine development. Int. J. Infect. Dis. 56, 268\u2013273, https:\/\/doi.org\/10.1016\/j.ijid.2017.01.030 (2017).","journal-title":"Int. J. Infect. Dis."},{"key":"60450_CR15","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1128\/IAI.00592-09","volume":"77","author":"PL Lin","year":"2009","unstructured":"Lin, P. L. et al. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77, 4631\u20134642, https:\/\/doi.org\/10.1128\/IAI.00592-09 (2009).","journal-title":"Infect. Immun."},{"key":"60450_CR16","doi-asserted-by":"publisher","first-page":"e1001012","DOI":"10.1371\/journal.pmed.1001012","volume":"8","author":"A Zwerling","year":"2011","unstructured":"Zwerling, A. et al. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med. 8, e1001012, https:\/\/doi.org\/10.1371\/journal.pmed.1001012 (2011).","journal-title":"PLoS Med."},{"key":"60450_CR17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10156-009-0686-8","volume":"15","author":"T Mori","year":"2009","unstructured":"Mori, T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J. Infect. Chemother. 15, 143\u2013155, https:\/\/doi.org\/10.1007\/s10156-009-0686-8 (2009).","journal-title":"J. Infect. Chemother."},{"key":"60450_CR18","doi-asserted-by":"publisher","first-page":"887","DOI":"10.11150\/kansenshogakuzasshi1970.68.887","volume":"68","author":"M Mori","year":"1994","unstructured":"Mori, M. et al. Analysis of children with tuberculosis in recent 10 years. Kansenshogaku Zasshi 68, 887\u2013893 (1994).","journal-title":"Kansenshogaku Zasshi"},{"key":"60450_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3109\/03009742.2015.1016103","volume":"44","author":"YJ Ha","year":"2015","unstructured":"Ha, Y. J. et al. Serum leucine-rich alpha2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still\u2019s disease. Scand. J. Rheumatol. 44, 399\u2013403, https:\/\/doi.org\/10.3109\/03009742.2015.1016103 (2015).","journal-title":"Scand. J. Rheumatol."},{"key":"60450_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jdermsci.2017.01.008","volume":"86","author":"H Nakajima","year":"2017","unstructured":"Nakajima, H., Serada, S., Fujimoto, M., Naka, T. & Sano, S. Leucine-rich alpha-2 glycoprotein is an innovative biomarker for psoriasis. J. Dermatol. Sci. 86, 170\u2013174, https:\/\/doi.org\/10.1016\/j.jdermsci.2017.01.008 (2017).","journal-title":"J. Dermatol. Sci."},{"key":"60450_CR21","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1080\/14397595.2016.1270795","volume":"27","author":"M Shimizu","year":"2017","unstructured":"Shimizu, M., Nakagishi, Y., Inoue, N., Mizuta, M. & Yachie, A. Leucine-rich alpha2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series. Mod. Rheumatol. 27, 833\u2013837, https:\/\/doi.org\/10.1080\/14397595.2016.1270795 (2017).","journal-title":"Mod. Rheumatol."},{"key":"60450_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep43732","volume":"7","author":"Y Kimura","year":"2017","unstructured":"Kimura, Y. et al. Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. Sci. Rep. 7, 43732, https:\/\/doi.org\/10.1038\/srep43732 (2017).","journal-title":"Sci. Rep."},{"key":"60450_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.clinbiochem.2017.02.010","volume":"50","author":"TH Rainer","year":"2017","unstructured":"Rainer, T. H. et al. Circulating human leucine-rich alpha-2-glycoprotein 1 mRNA and protein levels to detect acute appendicitis in patients with acute abdominal pain. Clin. Biochem. 50, 485\u2013490, https:\/\/doi.org\/10.1016\/j.clinbiochem.2017.02.010 (2017).","journal-title":"Clin. Biochem."},{"key":"60450_CR24","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/cas.13329","volume":"108","author":"M Yamamoto","year":"2017","unstructured":"Yamamoto, M. et al. Overexpression of leucine-rich alpha2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer. Cancer Sci. 108, 2052\u20132060, https:\/\/doi.org\/10.1111\/cas.13329 (2017).","journal-title":"Cancer Sci."},{"key":"60450_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4252-6","volume":"18","author":"E Shinozaki","year":"2018","unstructured":"Shinozaki, E. et al. Serum leucine-rich alpha-2-glycoprotein-1 with fucosylated triantennary N-glycan: a novel colorectal cancer marker. BMC Cancer 18, 406, https:\/\/doi.org\/10.1186\/s12885-018-4252-6 (2018).","journal-title":"BMC Cancer"},{"key":"60450_CR26","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1161\/CIRCHEARTFAILURE.110.952200","volume":"4","author":"CJ Watson","year":"2011","unstructured":"Watson, C. J. et al. Proteomic analysis of coronary sinus serum reveals leucine-rich alpha2-glycoprotein as a novel biomarker of ventricular dysfunction and heart failure. Circ. Heart Fail. 4, 188\u2013197, https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.110.952200 (2011).","journal-title":"Circ. Heart Fail."},{"key":"60450_CR27","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1210\/jc.2014-3855","volume":"100","author":"SL Pek","year":"2015","unstructured":"Pek, S. L. et al. Elevation of a novel angiogenic factor, leucine-rich-alpha2-glycoprotein (LRG1), is associated with arterial stiffness, endothelial dysfunction, and peripheral arterial disease in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 100, 1586\u20131593, https:\/\/doi.org\/10.1210\/jc.2014-3855 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60450_CR28","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1210\/jc.2017-00930","volume":"102","author":"JJ Liu","year":"2017","unstructured":"Liu, J. J. et al. Plasma Leucine-Rich alpha-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus. J. Clin. Endocrinol. Metab. 102, 3683\u20133691, https:\/\/doi.org\/10.1210\/jc.2017-00930 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"60450_CR29","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1681\/ASN.2018060599","volume":"30","author":"Q Hong","year":"2019","unstructured":"Hong, Q. et al. LRG1 Promotes Diabetic Kidney Disease Progression by Enhancing TGF-beta-Induced Angiogenesis. J. Am. Soc. Nephrol. 30, 546\u2013562, https:\/\/doi.org\/10.1681\/ASN.2018060599 (2019).","journal-title":"J. Am. Soc. Nephrol."},{"key":"60450_CR30","doi-asserted-by":"publisher","first-page":"e3029","DOI":"10.1002\/dmrr.3029","volume":"34","author":"SLT Pek","year":"2018","unstructured":"Pek, S. L. T. et al. Association of circulating proinflammatory marker, leucine-rich-alpha2-glycoprotein (LRG1), following metabolic\/bariatric surgery. Diabetes Metab. Res. Rev. 34, e3029, https:\/\/doi.org\/10.1002\/dmrr.3029 (2018).","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"Suppl 2","key":"60450_CR31","doi-asserted-by":"publisher","first-page":"B75","DOI":"10.1016\/j.vaccine.2009.09.079","volume":"28","author":"Y Yasutomi","year":"2010","unstructured":"Yasutomi, Y. Establishment of specific pathogen-free macaque colonies in Tsukuba Primate Research Center of Japan for AIDS research. Vaccine 28(Suppl 2), B75\u201377, https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.079 (2010).","journal-title":"Vaccine"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60450-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:17:43Z","timestamp":1670311063000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-60450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["60450"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-60450-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,25]]},"assertion":[{"value":"6 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.N. has received a grant from SEKISUI MEDICAL CO., LTD. For the remaining authors, there are no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3384"}}